Related Experiment Video

Updated: Sep 29, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Frequent hypermethylation of the RASSF1A gene in prostate cancer

Limin Liu1, Jung-Hoon Yoon, Reinhard Dammann

  • 1Department of Biology, Beckman Research Institute, City of Hope Cancer Center, Duarte, California, CA 91010, USA.

Oncogene
|October 3, 2002
PubMed

Insights

Epigenetic silencing of the RASSF1A gene through promoter methylation is common in prostate cancer. This RASSF1A gene methylation is linked to tumor aggressiveness and may play a role in disease progression.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Ras association domain family 1A gene (RASSF1A) is frequently lost in human solid tumors.
  • RASSF1A promoter hypermethylation is observed in various cancers, including lung, breast, and renal cell carcinoma.

Purpose of the Study:

  • To investigate the methylation status of RASSF1A in prostate tumors and cell lines.
  • To determine the correlation between RASSF1A methylation and prostate cancer aggressiveness.

Main Methods:

  • Analysis of RASSF1A promoter methylation in 52 primary prostate tumors and the LNCaP cell line.
  • Correlation analysis between methylation frequency and Gleason scores.
  • Assessment of RASSF1A expression restoration using 5-aza-2'-deoxycytidine.

Main Results:

  • RASSF1A promoter methylation was detected in 71% (37/52) of primary prostate tumors.
  • Higher methylation frequency was observed in aggressive tumors (Gleason score 7-10) compared to less malignant ones (Gleason score 4-6).
  • RASSF1A transcripts were absent in LNCaP cells with a hypermethylated promoter, and expression was restored upon treatment with a DNA methylation inhibitor.

Conclusions:

  • Epigenetic inactivation of RASSF1A via promoter methylation is a frequent event in prostate cancer.
  • RASSF1A methylation may contribute to prostate cancer progression.
  • RASSF1A methylation status could be a valuable biomarker for early detection, diagnosis, and prognosis in prostate cancer.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...